Bausch targets India-based firm over IBS drug generic

20-06-2023

Liz Hockley

Bausch targets India-based firm over IBS drug generic

Pavel Kapysh / Shutterstock.com

Pharma giant claims infringement of two patents | Hyderabad-based rival’s letter offering details of proposed generic allegedly lacked certain required details.


generic, Bausch, patents, Trulance, Orange Book, USPTO, ANDA, Salix Pharmaceuticals, MSN, Trulance, plecanatide,

LSIPR